Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Covis Group S.a.r.l.
Headquarters: Zug, Sweden
Website: N/A
Year Founded: 2011
Status: Acquired
BioCentury | Jan 25, 2024
Data Byte
EMA’s CHMP recommended fewer expedited approvals in 2023
The year also hit a new record for applications withdrawn during review
BioCentury | Mar 31, 2023
Data Byte
Bristol Myers cell therapy among EMA’s CHMP recommendations
Committee’s March opinions include label extension for Breyanzi, plus approvals of new therapies Briumvi, Omvoh and more
BioCentury | Mar 14, 2023
Management Tracks
Crabtree joins MorphoSys as CFO
Plus: Ultragenyx promotes Crombez to CMO and updates from Roche, Biogen and Bryn
BioCentury | Mar 9, 2023
Regulation
Makena shows why FDA wants confirmatory trials started before accelerated approval
A firestorm over pricing, a failed confirmatory trial and more than $1.5B in sales mark preterm birth drug’s 12-year journey from accelerated approval
BioCentury | Nov 10, 2022
Data Byte
Drug development for preterm birth still largely a no-fly zone
Of five disclosed programs to prevent preterm birth, three are preclinical while one clinical program was recently deprioritized
BioCentury | Oct 20, 2022
Deals
Oct. 19 Quick Takes: ‘Dark genome’ autoimmunity play Nucleome raises £37.5M series A
Plus venture rounds for Orionis, PIC, Inversago; PTC slips after pausing Huntington trial and more
BioCentury | Oct 4, 2022
Data Byte
October’s advisory committee lineup
A three-day hearing will determine the fate of Makena
BioCentury | Jul 16, 2022
Management Tracks
Aurinia hires EVP of R&D, commercial head and VP of IR
Plus Enveda names Gilead’s Sekar as CBO and Covis hires a Poulin as SVP, general manager
BioCentury | Feb 2, 2022
Management Tracks
Roche’s William Pao joins Pfizer as CDO
Plus Clevers succeeds Pao at Roche, new CEO, CFO and other changes at Sosei and updates from Biomea, BeiGene, Cortexyme and more
BioCentury | Dec 9, 2021
Management Tracks
Wilson joins gene therapy play Rocket
Plus updates from Tessera, Oramed, Ikena and more
Items per page:
1 - 10 of 15